Clofazimine should be used in all cases of leprosy, says Indian research council

BMJ 2013; 346 doi: (Published 26 March 2013) Cite this as: BMJ 2013;346:f1963
  1. Soumyadeep Bhaumik
  1. 1Kolkata

Clofazimine should be added to the regimen of drugs used to treat paucibacillary leprosy, the Indian Council of Medical Research has recommended.1

Clofazimine is a lipophilic riminophenazine antibiotic with antibacterial and anti-inflammatory properties. The latest recommendation from the Indian Council of Medical Research is based on a review it conducted on published data that showed that clofazimine “can be safely used . . . along with dapsone and rifampicin for the 6 month multidrug therapy (MDT) being used in the treatment of paucibacillary leprosy.”

India achieved …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial